Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet Announces Board and Management Changes
Patrick Sullivan Elected Chairman of the Board Jessica Hopfield , PhD, Assumes Role of Lead Independent Director Shacey Petrovic Promoted to President and Chief Operating Officer Daniel Levangie Announces Retirement BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet
View HTML
Toggle Summary Insulet Corporation to Announce Third Quarter 2016 Financial Results on November 3, 2016
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2016 on November 3, 2016
View HTML
Toggle Summary Insulet Enrolls First Patients in Clinical Trial for its Omnipod® Artificial Pancreas System
Study Brings Insulet Another Step Closer to Providing its Omnipod ® Horizon ™ Hybrid Closed Loop System to People with Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet Announces Pricing of Convertible Senior Notes Due 2021
Proceeds for General Corporate Purposes, Including Repurchase of a Portion of Outstanding 2% Convertible Senior Notes Due 2019 and Investment in Manufacturing and Supply Chain BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), a leader in tubeless
View HTML
Toggle Summary Insulet Announces Private Offering of Convertible Senior Notes
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ:PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced its intention to offer, subject to market and other conditions, $250 million
View HTML
Toggle Summary Insulet to Establish Highly-Automated Manufacturing Operation in the United States
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced plans to establish an automated manufacturing operation in the United
View HTML
Toggle Summary Insulet Announces Executive Appointments
Dr. Trang Ly , Prominent Artificial Pancreas Researcher, Appointed Vice President and Medical Director Brittany Bradrick Appointed Vice President, Strategy and Corporate Development BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), the leader in
View HTML
Toggle Summary Insulet Reports Second Quarter 2016 Financial Results
Second Quarter Revenue of $87.3 Million , up 44% Year-Over-Year, Exceeds Expectations Company Raises Mid-Point of Full Year 2016 Revenue Guidance by $10 Million Gross Margin Improves to 57.8% BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conferences
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences in New York City ,
View HTML
Toggle Summary Insulet Launches New Educational iPad App: Toby's T1D Tale
Omnipod ® Mascot Provides Diabetes Education to Children and Caregivers through Stories, Tips and Trivia BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System
View HTML
Toggle Summary Insulet Corporation to Announce Second Quarter 2016 Financial Results on August 3, 2016
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2016 on August 3, 2016
View HTML
Toggle Summary New Data Demonstrate Benefits of Insulet's Omnipod® System for People with Type 1 and Type 2 Diabetes
Two Publications in the Journal of Diabetes Science and Technology BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD), the leader in tubeless insulin pump technology with its Omnipod Insulin Management System (Omnipod System), today announced two online publications of new
View HTML
Toggle Summary Insulet Partners with Joslin Diabetes Center to Implement a Unique Training Certification for Insulet's Clinical Team
Insulet's Clinical Team Receives Certification in Advanced Diabetes Educator in Pump Therapy (ADEPT™) Program BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management
View HTML
Toggle Summary Insulet to Present Omnipod® Clinical Studies on Type 1 and Type 2 Diabetes During the American Diabetes Association's 76th Scientific Sessions
Company Presentations Include Compelling Clinical Data Demonstrating the Efficacy of the Omnipod System on Glycemic Control in Patients with Type 1 and Type 2 Diabetes Dr. Frank Doyle to Share Exciting New Data on the Insulet-Licensed Artificial Pancreas Algorithm Company Exhibiting at Booth 1301;
View HTML
Toggle Summary Insulet Launches New Omnipod® Podder™ Community Platform
New Platform Provides Enhanced Support, Information, and Social Engagement for Growing Community of Podders BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management
View HTML